COVID-19 Editorial: Mechanistic Links and Daunting Therapeutic Challenges for Metabolic Diseases One Year after The Beginning of The COVID-19 Pandemic

Accumulating evidence has clearly suggested that cardiometabolic risk factors such as obesity, hypertension, dyslipidemia and diabetes mellitus (DM) are associated with a more severe disease course and worse clinical outcomes of coronavirus disease 2019 (COVID-19) [1].

Source: Metabolism - Clinical and Experimental - March 25, 2021 Category: Biomedical Science Authors: Christopher M. Tessier, Alexander Kokkinos, Geltrude Mingrone, Chrysi Koliaki, Juleen R. Zierath, Christos S. Mantzoros Tags: Commentary Source Type: research